Related Experiment Video

Updated: Aug 8, 2026

Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

Stimulated cellular immune system in patients with congestive heart failure

D Fuchs1, M Samsonov, G P Tilz

  • 1Institut für Medizinische Chemie und Biochemie, Universität Innsbruck, Austria.

European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|March 1, 1993
PubMed

Insights

Cellular immunity markers like neopterin and soluble interleukin-2 receptor are elevated in congestive heart failure patients, suggesting immune system activation. These findings link immune response to heart failure progression.

Area of Science:

  • Immunology
  • Cardiology
  • Biochemistry

Background:

  • Congestive heart failure (CHF) is associated with complex pathophysiological mechanisms.
  • Immune system dysregulation may play a role in CHF progression.

Purpose of the Study:

  • To investigate serum concentrations of soluble markers of cellular immune activation in patients with CHF.
  • To explore potential correlations between these markers and immune cell activity.

Main Methods:

  • Cross-sectional study analyzing serum concentrations of interferon-gamma, neopterin, soluble interleukin-2 receptor, and soluble CD8.
  • Comparison of marker levels against reference ranges from healthy controls.
  • Statistical analysis to identify significant correlations between markers.

Main Results:

  • Elevated neopterin (40%), soluble interleukin-2 receptor (56%), and soluble CD8 (24%) were observed in CHF patients.
  • Interferon-gamma was detectable in 40% of patients.
  • Significant positive correlations found between neopterin and interferon-gamma (rs = 0.417, p < 0.05), and neopterin and soluble CD8 (rs = 0.430, p < 0.05).
  • All patients with increased soluble CD8 also showed increased soluble interleukin-2 receptor.

Conclusions:

  • Increased levels of neopterin, soluble interleukin-2 receptor, and soluble CD8 indicate stimulated cellular immunity in CHF.
  • Activated CD8-positive T-lymphocytes may be a source of elevated soluble CD8.
  • Interferon-gamma from activated T-cells might induce neopterin release from monocytes/macrophages, highlighting a potential immune pathway in CHF.

More Related Videos

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...